CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.6100
+0.0100 (1.67%)
At close: Mar 18, 2026, 4:00 PM EDT
0.5805
-0.0295 (-4.84%)
After-hours: Mar 18, 2026, 7:56 PM EDT

CollPlant Biotechnologies Revenue

CollPlant Biotechnologies had revenue of $77.00K in the quarter ending September 30, 2025, with 1,825.00% growth. This brings the company's revenue in the last twelve months to $2.48M, up 280.77% year-over-year. In the year 2024, CollPlant Biotechnologies had annual revenue of $515.00K, down -95.30%.

Revenue (ttm)
$2.48M
Revenue Growth
+280.77%
P/S Ratio
3.25
Revenue / Employee
$43,421
Employees
57
Market Cap
7.79M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024515.00K-10.44M-95.30%
Dec 31, 202310.96M10.66M3,565.22%
Dec 31, 2022299.00K-15.34M-98.09%
Dec 31, 202115.64M9.50M154.86%
Dec 31, 20206.14M3.82M164.75%
Dec 31, 20192.32M-2.70M-53.77%
Dec 31, 20185.01M4.55M982.94%
Dec 31, 2017463.00K387.12K510.15%
Dec 31, 201675.88K--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evogene3.85M
SciSparc1.31M
Kiora Pharmaceuticals20.00K
Pulmatrix3.00K
Ernexa Therapeutics1,000.00
Revenue Rankings